Archive

Filter

Shares of Airgain (NSDQ: AIRG) have exploded to the upside after a much better than expected earnings report released last week.  I am recommending taking profits on the position with a near 50% gain in the shares as of the open of trading on November 15.  Shares were initially… Read More

Certain biotech stocks, such as Gilead are likely to respond to changes in the healthcare system brought about by Trumpcare.  This trade has yet to develop fully, yet has an excellent chance to deliver a significant profit once the stock breaks up or down.  Read More

Our primary play in the cancer immunotherapy field, Argos Therapeutics (ARGS), issued its third quarter results this morning that were in line with expectations. Shares of ARGS were down slightly in early trading this morning. The company reported a net loss of $0.32 per share compared a loss of $0.97… Read More

Back in July I recommended buying KEYW Holding (NSDQ: KEYW), which since then had drifted along until last week. A tiny company that’s specializes in cybersecurity and geospatial intelligence, it also owns a fleet of small planes capable of specialized intelligence gathering. Its business outlook was improving at the time… Read More

Shares of Airgain (NSDQ: AIRG), a leading provider of embedded premium high-performance antennas for electronic devices, rallied after it reported well-above expected earnings for its quarter ending on September 30, 2016. The company reported $12.4 million in sales, an 87% improvement over the prior year while delivering 16 cents per… Read More

The rising uncertainty about a healthcare system under President Trump is starting to sink in and the market seems to be in sell mode for pharmaceutical companies. So it’s a good time to sell Opko Health (NSDQ: OPK), a company specializing in hormone treatments and kidney dialysis related treatments, with… Read More

It’s time to close out the Anthem straddle. The trade has delivered an excellent gain and we don’t want to let the time premium and the upcoming weekend erode into our profit.SELL to close Anthem December 16, 120 Strike Price Put (ATNM121616P120)  Bought on 8/29/16 at $5.15. Closing price on 11/10/16… Read More

The post-election rally seems to have some short-term legs and the healthcare stocks are putting on quite a show. The early indications suggest that money is aggressively flowing into the health insurance companies. As a result, a change of tactics is called for.I recommend the sale of the Johnson &… Read More

If the events that unfolded on Sunday, with FBI Director James Comey seeming to cancel any potential legal problems for Democratic presidential candidate Hillary Clinton, are any sign of what’s to come, investors should prepare for an extraordinary election day and post-election market.The Waiting GameIt’s not difficult to get… Read More